Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Oxidative stress and thyroid hormones in patients with liver diseases.

Moustafa AH, Ali EM, Mohamed TM, Abdou HI.

Eur J Intern Med. 2009 Nov;20(7):703-8. doi: 10.1016/j.ejim.2009.08.003. Epub 2009 Sep 10.

PMID:
19818291
2.

Hepatitis C Viral Kinetics in Special Populations.

Dahari H, Layden-Almer JE, Perelson AS, Layden TJ.

Curr Hepat Rep. 2008;7(3):97-105.

3.

Resveratrol inhibits nonalcoholic fatty liver disease in rats.

Bujanda L, Hijona E, Larzabal M, Beraza M, Aldazabal P, García-Urkia N, Sarasqueta C, Cosme A, Irastorza B, González A, Arenas JI Jr.

BMC Gastroenterol. 2008 Sep 9;8:40. doi: 10.1186/1471-230X-8-40.

4.

Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon alpha-2b and ribavirin.

Murakami Y, Koyabu T, Kawashima A, Kakibuchi N, Kawakami T, Takaguchi K, Kita K, Okita M.

J Nutr Sci Vitaminol (Tokyo). 2007 Jun;53(3):213-8.

5.

The effect of different combination therapies on oxidative stress markers in HIV infected patients in Cameroon.

Ngondi JL, Oben J, Forkah DM, Etame LH, Mbanya D.

AIDS Res Ther. 2006 Jul 22;3:19.

6.

A novel antioxidant N-acetylcysteine amide prevents gp120- and Tat-induced oxidative stress in brain endothelial cells.

Price TO, Uras F, Banks WA, Ercal N.

Exp Neurol. 2006 Sep;201(1):193-202. Epub 2006 Jun 5.

PMID:
16750528
7.

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.

Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, S Sulkowski M, Torriani FJ, Dieterich DT, Thomas DL, Messinger D, Nelson M; APRICOT Clinical Investigators.

Hepatology. 2006 Jun;43(6):1317-25.

PMID:
16729309
8.

Hepatic steatosis associated with hepatitis C virus infection.

Cornianu M, Dema A, Tăban S, Lazăr D, Lazăr E, Costi S.

Rom J Morphol Embryol. 2005;46(4):283-9.

9.

Morbidity and mortality profile of human immunodeficiency virus-infected patients with and without hepatitis C co-infection.

Mayor AM, Gomez MA, Fernandez DM, Rios-Olivares E, Thomas JC, Hunter RF.

Am J Trop Med Hyg. 2006 Feb;74(2):239-45.

10.

Viral load is a negative predictor of antioxidant levels in hepatitis C patients.

Grønbaek K, Sonne J, Ring-Larsen H, Poulsen HE, Friis H, Bygum Krarup H.

Scand J Infect Dis. 2005;37(9):686-9.

PMID:
16126571
11.

Differential contribution of hepatitis C virus NS5A and core proteins to the induction of oxidative and nitrosative stress in human hepatocyte-derived cells.

García-Mediavilla MV, Sánchez-Campos S, González-Pérez P, Gómez-Gonzalo M, Majano PL, López-Cabrera M, Clemente G, García-Monzón C, González-Gallego J.

J Hepatol. 2005 Oct;43(4):606-13.

PMID:
16112247
12.

Mitochondrial DNA depletion in HIV-infected patients is more pronounced with chronic hepatitis C and enhanced following treatment with pegylated interferon plus ribavirin.

de Mendoza C, Sánchez-Conde M, Timmermans E, Buitelaar M, de Baar MP, Gonzalez-Lahoz J, Soriano V.

Antivir Ther. 2005;10(4):557-61.

PMID:
16038482
13.

Effect of interferon, ribavirin and ursodeoxycholic acid in patients with hepatitis C infection.

Ljubuncic P, Konikoff FM, Blendis LM, Bomzon A.

Hepatogastroenterology. 2005 Jul-Aug;52(64):1191-6.

PMID:
16001659
14.

Mitochondrial dysfunction in hepatitis C.

Korenaga M, Okuda M, Otani K, Wang T, Li Y, Weinman SA.

J Clin Gastroenterol. 2005 Apr;39(4 Suppl 2):S162-6. Review.

PMID:
15758653
15.

Immune activation and oxidative damage in HIV-positive and HIV-negative adolescents.

Stephensen CB, Marquis GS, Douglas SD, Wilson CM.

J Acquir Immune Defic Syndr. 2005 Feb 1;38(2):180-90.

PMID:
15671803
16.

Oxidative stress in viral hepatitis and AIDS.

Stehbens WE.

Exp Mol Pathol. 2004 Oct;77(2):121-32. Review.

PMID:
15351235
17.

Oxidative stress in chronic hepatitis C: the effect of interferon therapy and correlation with pathological features.

Serejo F, Emerit I, Filipe PM, Fernandes AC, Costa MA, Freitas JP, de Moura MC.

Can J Gastroenterol. 2003 Nov;17(11):644-50.

PMID:
14631465
18.

Effect of vitamin E on serum aminotransferase and thioredoxin levels in patients with viral hepatitis C.

Mahmood S, Yamada G, Niiyama G, Kawanaka M, Togawa K, Sho M, Ito T, Sasagawa T, Okita M, Nakamura H, Yodoi J.

Free Radic Res. 2003 Jul;37(7):781-5.

PMID:
12911275
19.

Contribution to characterization of oxidative stress in HIV/AIDS patients.

Gil L, Martínez G, González I, Tarinas A, Alvarez A, Giuliani A, Molina R, Tápanes R, Pérez J, León OS.

Pharmacol Res. 2003 Mar;47(3):217-24.

PMID:
12591017
20.

Oxidative stress EPR measurement in human liver by radical-probe technique. Correlation with etiology, histology and cell proliferation.

Valgimigli M, Valgimigli L, Trerè D, Gaiani S, Pedulli GF, Gramantieri L, Bolondi L.

Free Radic Res. 2002 Sep;36(9):939-48.

PMID:
12448819

Supplemental Content

Support Center